疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

+ u+ O; S# ^6 [- M3 n8 }3 R

Vaccines, 6th Edition

6 o) I) N% V! V( q) ^8 rApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
2 Z" e" z# K$ s% D0 W/ H/ }
& P0 t; [9 k" ~  h/ C9 {( Nhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

1 p0 s+ u1 C1 N# ^2 ySECTION 1: General aspects of vaccination
2 y& M1 J' P# b. _2 g1 A short history of vaccination 1
2 Vaccine immunology 14
  Z$ w+ z" ?" j( b* g! @3 The vaccine industry 33
4 Vaccine manufacturing 44
9 O1 }: ]4 U* N5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
+ T8 g+ u$ @4 e7 ^! C9 Adenovirus vaccines 113
10 Anthrax vaccines 127
11 Cholera vaccines 141
, f- Y- ]& \5 d& b' R12 Diphtheria toxoid 153
: s- F! |  d1 x% L# A5 z$ O, V13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
* y3 ~* ^9 i9 l  u6 ?8 x6 I15 Hepatitis B vaccines 205
' B) L6 t5 P; Y- y/ y16 Human papillomavirus vaccines 235
* Y. y7 t- h& }$ m, B+ B4 X8 ?8 L17 Inactivated influenza vaccines 257
7 E9 f( R. s) W+ ^7 |( I  q18 Influenza vaccine-live 294
/ ~: H2 u5 U$ ]19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
8 M+ j( A# J( E9 z22 Mumps vaccine 419
23 Pertussis vaccines . 447
, |* i. p9 `; H" g) z- a  O$ M24 Plague vaccines 493
# C3 J" H# e* f4 M! i25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
' K1 r& w4 H' N! Q* I26 Pneumococcal polysaccharide vaccines 542
9 g- X9 N5 t+ d1 o- a27 Poliovirus vaccine-inactivated . 573
  G& T' O) b: _; [. I28 Poliovirus vaccine-live 598
4 M. m/ r7 F' ]. t29 Rabies vaccines .646
. ]- v! S3 \' {# m6 e, F30 Rotavirus vaccines . 669
- I+ P" |. U$ \31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
. C0 ^) t" u$ w: j34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
6 s9 v4 w6 F& q1 F: s37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
9 p$ [- U1 E. T, C9 O' g40 Combination vaccines 981
! ~0 v6 W. O+ |2 qSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
7 I- i2 Y% W& h' @42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
5 k- Z& W/ ?) y" D7 {/ g44 Dengue vaccines 1042
3 C8 s' N0 f8 O( i45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
3 ?4 e! `  D6 I8 S, y( i* ~% H47 Epstein-Barr virus vaccines 1068
# b/ m" C1 p, @7 [* _48 Hepatitis C vaccines 1074
2 S- S4 g/ u. c: [9 X49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
8 C6 \3 q# D" P+ g' Q3 e' R52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
6 V6 p- w5 W' B; _- m( `% l4 N' M54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
6 z! A3 a; @2 T0 A56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
6 \4 _- n5 \0 k7 s  L  X9 H59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
  `6 I0 ?' Z7 g3 r  T61 Alternative vaccine delivery methods 1200
5 ]  X* k- ]# t, R+ j0 j62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
2 W7 k- J8 f  S1 f6 u% [. G63 Vaccination of immunocompromised hosts 1243
, S5 i: h; w! i& N; A64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
& f+ `; N/ k' [66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
6 ]7 W1 B) _4 o) U( _70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
. X- _8 N+ H3 L$ G/ D/ \! G74 Regulation of vaccines in Europe 1447
; ^  h- u# k* I7 d75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
, M. m+ u  z) W5 F+ P78 Ethics 1508


& m& T+ A; a. g4 s4 u

' V$ x$ [. U) G: n! A

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

+ @9 L# f3 c( ]/ u5 A" ?Vaccines, 6th Edition
2 s; [9 t/ f* E: ]9 F2 H4 v  z
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
. _, d$ I) ?3 J. Q7 l8 R
http://yun.baidu.com/share/link? ... 1&uk=3810996606
) y. ?. n' s# y* Z4 I6 }$ H% G) ]0 ~7 w
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
8 e& ]3 u/ u5 ], H2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
2 W) d- h7 e% d6 t/ t2 K9 J7 c5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
! L, m( R6 Z  a6 ]$ Jlicensed vaccines 71
7 Passive immunization 80
- o8 _3 ]# ~/ r3 {4 D2 O8 General immunization practices 88
. ^; a; y: q) G, D+ K# KSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
10 Anthrax vaccines 127
- o; e. Z. N$ o+ n11 Cholera vaccines 141
12 Diphtheria toxoid 153
& m. F2 G* c+ n+ E13 Haemophilus influenzae vaccines 167
; b" D8 m) N6 |1 c6 `, ^14 Hepatitis A vaccines 183
- e( R5 Z1 d* \  H- g3 |6 K; s4 J3 @15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
# @8 I6 G4 K& H& e3 D( k17 Inactivated influenza vaccines 257
. X; ~, f8 N0 N: J& Q2 L18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
2 ^' W. z, ~. _0 Z: C6 G8 j4 D/ v0 q5 a22 Mumps vaccine 419
23 Pertussis vaccines . 447
2 F( B4 E, G& h% |" @24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
' V, K7 v; }; s! h26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
" m$ ]/ F! m6 s3 I29 Rabies vaccines .646
7 C9 D- j3 W0 t, N0 x  p5 b% J30 Rotavirus vaccines . 669
. p# m8 n* `# H  y! m31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
. C7 G7 u9 A5 X34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
; |0 W7 P+ X; k  ?& \$ K8 `36 Typhoid fever vaccines 812
" y) N4 g* F1 B; N% X4 D7 c2 y  S, h" X37 Varicella vaccine 837
% P% i) z% Z) p; i3 V7 r! F38 Yellow fever vaccine 870
3 _7 G6 P& U7 p% n) W" z39 Zoster vaccine 969
. Q. V* B( j6 m- n. _0 o40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
. ]" V) @9 ?1 t41 Biodefense and special pathogen vaccines 1008
2 y4 h2 O' ?: q2 q* V5 T: Z42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
; ^: D, ~1 t8 T45 Diarrhea caused by bacteria 1052
, g5 F& R- P: _& J46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
3 k; ?% c) a% S6 f  w9 ^48 Hepatitis C vaccines 1074
9 y8 a& e. L( \  \# h' P49 Hepatitis E vaccines 1085
3 W/ {1 f0 j+ U* x$ Y6 y50 Herpes simplex virus vaccines 1090
- O5 |# o5 C2 z7 E51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
( S3 s- L0 ~1 r$ A56 Parasitic disease vaccines 1154
; d# T) N' y8 ~3 F+ P/ y4 Z: F6 I57 Staphylococcus aureus vaccines 1161
2 f0 O- Q# x3 C# P- Q( I58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
! K/ }' U# K8 R61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
' ~( u3 y8 w; W63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
' R% j( V5 i, W8 i* pSECTION 5: Public health and regulatory issues
8 F4 T( J! s1 a2 O! x! ?+ v67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
4 a, ?6 s6 u. V& c$ `4 Q71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
; L: k" K$ E1 v/ r' y74 Regulation of vaccines in Europe 1447
! p# B! J+ M" T75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
) }/ s+ |. ]! B  ^  |1 q78 Ethics 1508

casarett

Vaccines, 6e, 2012
- q! a' K) Y; ]3 l5 V
3 `7 V3 z' _3 `) t- y* Q3 K8 v$ U, \Hardcover: 1570 pages
! z- S# O4 W8 H) U* dPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
! A: }, \9 Y6 t! Y( W5 h  k1 QISBN-10: 1455700908
) r+ \( z8 v3 y0 [+ LSize: 52.3mb (original pdf)
, w: S# [2 u. F9 _  h; q
0 {' u$ j. X; c) h6 ~% l6 h! h2013 BMA Medical Book Awards Highly Commended in Public Health!
& L" ?% K9 Y+ m* D+ LApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
: k& O5 g3 C& T3 |' bGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
! Q+ R2 b2 W- p0 FClearly visualize concepts and objective data through an abundance of tables and figures.
" h5 `2 u3 Y/ i$ u* HPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
, X& {& i; k* _8 q1 h3 C$ ?0 xMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
0 o3 J/ M/ K, h% m. }Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96